A Phase I Study of Hyperthermic Isolated Hepatic Perfusion with Oxaliplatin in the Treatment of Unresectable Liver Metastases from Colorectal Cancer

By Zeh Herbert   Brown Charles   Holtzman Matthew   Egorin Merrill   Holleran Julianne   Potter Douglas   Bartlett David  

Annals of Surgical Oncology, Vol. 16, Iss. 2, 2009-02 ,pp. : 385-394

Springer Publishing Company

Access to resources Recommend Favorite

Percutaneous laser ablation in patients with isolated unresectable liver metastases from colorectal cancer: Results of a phase II study

By Pacella Claudio   Valle Dario   Bizzarri Giancarlo   Pacella Sara   Brunetti Maurizio   Maritati Raffaele   Osborn John   Stasi Roberto  

Acta Oncologica, Vol. 45, Iss. 1, 2006-02 ,pp. : 77-83

Informa Healthcare

Access to resources Recommend Favorite

Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study

By Martin Robert  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 192-198

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Trial of Isolated Hepatic Perfusion (IHP) Using 5-FU and Oxaliplatin in Patients with Unresectable Isolated Liver Metastases from Colorectal Cancer

By Magge D.   Zureikat A.   Bartlett D.   Holtzman M.   Choudry H.   Beumer J.   Pingpank J.   Holleran J.   Strychor S.   Cunningham D.   Jones H.   Zeh H.  

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2180-2187

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study

By Takahashi Takao  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 335-342

Springer Publishing Company

Access to resources Recommend Favorite